Literature DB >> 31800331

Antimicrobial resistance in Clostridium difficile ribotype 017.

Korakrit Imwattana1,2, Daniel R Knight3, Brian Kullin4, Deirdre A Collins5, Papanin Putsathit5, Pattarachai Kiratisin2, Thomas V Riley1,3,5,6.   

Abstract

Introduction: Antimicrobial resistance (AMR) played an important role in the initial outbreaks of Clostridium difficile infection (CDI) in the 1970s. C. difficile ribotype (RT) 017 has emerged as the major strain of C. difficile in Asia, where antimicrobial use is poorly regulated. This strain has also caused CDI outbreaks around the world for almost 30 years. Many of these outbreaks were associated with clindamycin and fluoroquinolone resistance. AMR and selective pressure is likely to be responsible for the success of this RT and may drive future outbreaks.Areas covered: This narrative review summarizes the prevalence and mechanisms of AMR in C. difficile RT 017 and transmission of these AMR mechanisms. To address these topics, reports of outbreaks due to C. difficile RT 017, epidemiologic studies with antimicrobial susceptibility results, studies on resistance mechanisms found in C. difficile and related publications available through Pubmed until September 2019 were collated and the findings discussed.Expert opinion: Primary prevention is the key to control CDI. This should be achieved by developing antimicrobial stewardship in medical, veterinary and agricultural practices. AMR is the key factor that drives CDI outbreaks, and methods for the early detection of AMR can facilitate the control of outbreaks.

Entities:  

Keywords:  Antimicrobial resistance; Clostridium difficile; outbreak; prevention; ribotype 017

Mesh:

Substances:

Year:  2019        PMID: 31800331     DOI: 10.1080/14787210.2020.1701436

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  7 in total

Review 1.  Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens.

Authors:  Jennifer Venhorst; Jos M B M van der Vossen; Valeria Agamennone
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

2.  Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.

Authors:  Tanya Lew; Papanin Putsathit; Kyung Mok Sohn; Yuan Wu; Kentaro Ouchi; Yoshikazu Ishii; Kazuhiro Tateda; Thomas V Riley; Deirdre A Collins
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 3.  Antimicrobial resistance in Clostridioides difficile.

Authors:  Keeley O'Grady; Daniel R Knight; Thomas V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-08-24       Impact factor: 3.267

4.  Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.

Authors:  Deirdre A Collins; Yuan Wu; Kazuhiro Tateda; Hee-Jung Kim; Richard J Vickers; Thomas V Riley
Journal:  J Antimicrob Chemother       Date:  2021-03-12       Impact factor: 5.790

5.  A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile.

Authors:  Korakrit Imwattana; César Rodríguez; Thomas V Riley; Daniel R Knight
Journal:  Microb Genom       Date:  2021-11

6.  Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017.

Authors:  Korakrit Imwattana; Papanin Putsathit; Deirdre A Collins; Teera Leepattarakit; Pattarachai Kiratisin; Thomas V Riley; Daniel R Knight
Journal:  Microb Genom       Date:  2022-03

Review 7.  Mechanisms of antibiotic resistance of Clostridioides difficile.

Authors:  Ishani Wickramage; Patrizia Spigaglia; Xingmin Sun
Journal:  J Antimicrob Chemother       Date:  2021-11-12       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.